BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23186308)

  • 1. Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation.
    Ji K; Zhao L; Yang C; Meng M; Wang P
    Radiat Oncol; 2012 Nov; 7():200. PubMed ID: 23186308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.
    Zhang WZ; Chen JZ; Li DR; Chen ZJ; Guo H; Zhuang TT; Li DS; Zhou MZ; Chen CZ
    World J Gastroenterol; 2014 Oct; 20(38):13973-80. PubMed ID: 25320535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.
    Zhao L; Chen M; Ten Haken R; Chetty I; Chapet O; Hayman JA; Kong FM
    Radiother Oncol; 2007 Feb; 82(2):153-9. PubMed ID: 17287040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.
    Li M; Zhang X; Zhao F; Luo Y; Kong L; Yu J
    Radiat Oncol; 2016 Feb; 11():18. PubMed ID: 26846932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental nodal irradiation in patients with esophageal cancer undergoing (chemo)radiation with 3D-CRT or VMAT.
    Peschel DP; Düsberg M; Peeken JC; Kaiser JC; Borm KJ; Sommer K; Combs SE; Münch S
    Sci Rep; 2022 Dec; 12(1):22333. PubMed ID: 36567356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
    Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
    Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
    Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?
    Zhao KL; Ma JB; Liu G; Wu KL; Shi XH; Jiang GL
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):446-51. PubMed ID: 20004527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
    J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
    Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
    Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caution against simultaneous integrated boost radiotherapy for upper thoracic esophageal squamous cell carcinoma: results from a single-arm phase II trial.
    Zhou Y; Chu L; Lu S; Chu X; Ni J; Li Y; Guo T; Yang X; Zhu Z
    Esophagus; 2023 Oct; 20(4):713-721. PubMed ID: 37149827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.
    Li Q; Zhu S; Li S; Deng W
    Medicine (Baltimore); 2019 Jan; 98(3):e14080. PubMed ID: 30653123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
    Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-conformal RT, fixed-field IMRT and RapidArc, which one is better for esophageal carcinoma treated with elective nodal irradiation.
    Wang D; Yang Y; Zhu J; Li B; Chen J; Yin Y
    Technol Cancer Res Treat; 2011 Oct; 10(5):487-94. PubMed ID: 21895033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
    Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
    Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases.
    Huang W; Li B; Gong H; Yu J; Sun H; Zhou T; Zhang Z; Liu X
    Radiother Oncol; 2010 May; 95(2):229-33. PubMed ID: 20189259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
    Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
    Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
    J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.